Growth Metrics

Insulet (PODD) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.10%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 5.54%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.09%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 14.70%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 5.29%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 7.15%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 13.40%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 12.36%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 20.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.74%
Dec 31, 2025 21.92%
Sep 30, 2025 22.88%
Jun 30, 2025 -12.51%
Mar 31, 2025 24.20%
Dec 31, 2024 32.49%
Sep 30, 2024 30.20%
Jun 30, 2024 23.61%
Mar 31, 2024 18.19%
Dec 31, 2023 -6.63%
Sep 30, 2023 16.74%
Jun 30, 2023 31.20%
Mar 31, 2023 15.27%
Dec 31, 2022 11.87%
Sep 30, 2022 10.89%
Jun 30, 2022 10.50%
Mar 31, 2022 17.88%
Dec 31, 2021 10.96%
Sep 30, 2021 -20.12%
Jun 30, 2021 9.07%
Mar 31, 2021 1.68%
Dec 31, 2020 23.17%
Sep 30, 2020 -9.47%
Jun 30, 2020 -8.34%
Mar 31, 2020 3.51%
Dec 31, 2019 5.74%
Sep 30, 2019 2.85%
Jun 30, 2019 14.61%
Mar 31, 2019 3.24%
Dec 31, 2018 5.73%
Sep 30, 2018 56.19%
Jun 30, 2018 17.05%
Mar 31, 2018 15.53%
Dec 31, 2017 25.03%
Sep 30, 2017 -2.74%
Jun 30, 2017 21.32%
Mar 31, 2017 17.78%
Dec 31, 2016 32.90%
Sep 30, 2016 27.08%
Jun 30, 2016 12.72%
Mar 31, 2016 20.73%
Dec 31, 2015 30.08%
Sep 30, 2015 22.44%
Jun 30, 2015 20.05%
Mar 31, 2015 26.69%
Dec 31, 2014 26.03%
Sep 30, 2014 75.14%
Jun 30, 2014 32.81%
Mar 31, 2014 30.52%
Dec 31, 2013 37.58%
Sep 30, 2013 32.46%